Results 91 to 100 of about 164,924 (263)

Helicobacter pylori type IV secretion apparatus exploits beta1 integrin in a novel RGD-independent manner. [PDF]

open access: yes, 2009
Translocation of the Helicobacter pylori (Hp) cytotoxin-associated gene A (CagA) effector protein via the cag-Type IV Secretion System (T4SS) into host cells is a major risk factor for severe gastric diseases, including gastric cancer.
Haas, Rainer   +42 more
core   +2 more sources

Is Less More? An Update on Aspirin for Cancer Prevention in Lynch Syndrome From the Cancer Prevention Programme—CaPP

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT Aspirin has been used to treat pain and fever for 120 years. Its uses expanded into treating arthritis and prevention of thrombotic events. Its anti‐cancer role emerged with observational studies in the 1980's and subsequent cancer review in those treated with aspirin in cardiovascular trials.
John Burn, D. Timothy Bishop
wiley   +1 more source

Gastric infection with Kazachstania heterogenica influences the outcome of a Helicobacter suis infection in Mongolian gerbils

open access: yes, 2010
Background: The Mongolian gerbil model is often used to investigate the interactions between different gastric Helicobacter species and the gastric tissue.
Flahou, Bram   +11 more
core   +1 more source

IgG and IgA-antibodies to Helicobacter pullorum, H bilis and H-pylori in sera and bile samples from patients with cholelithiasis [PDF]

open access: yes, 2010
AIM: To analyse the possible association of various Helicobacter species and certain common gut bacteria in patients with Meckel's diverticulum and appendicitis.
Nilsson, Ingrid   +21 more
core   +1 more source

Human biomarker navigator

open access: yesiMeta, EarlyView.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li   +29 more
wiley   +1 more source

Asociación de la lesión gástrica y la infección por helicobacter pylory en pacientes pediátricos Gastric lesion associated with the infection caused by Helicobacter Pylori in paediatric patients

open access: yesRevista de Ciencias Médicas de Pinar del Río, 2009
Se realizó una investigación longitudinal y prospectiva, de las 249 biopsias gástricas diagnosticadas como lesión gástrica inflamatoria, a las cuales se les determinó la presencia de la infección por Helicobacter pylori, mediante la técnica de fucsina ...
Lissette Sixto Cordero   +4 more
doaj  

Lectin-conjugated microspheres for eradication of Helicobacter pylori infection and interaction with mucus [PDF]

open access: yes, 2014
Using second generation mucoadhesives may enhance targeting antibiotics for eradication of Helicobacter pylori from the stomach for the treatment of peptic ulcer.
Conway, Barbara R   +2 more
core   +1 more source

Infection mechanisms of Rhizoctonia cerealis in wheat

open access: yesiMeta, EarlyView.
We discover that R. cerealis (Rc) is a primary pathogen causing sharp eyespot of wheat after 335 distinct isolates were isolated from 1683 SE‐diseased wheat plants across China over 7 years using a single hyphal tip isolation method. We then generated high‐quality reference genomes via de novo sequencing of five representative Rc isolates and ...
Yan Ren   +13 more
wiley   +1 more source

Does N-acetyl cystein affect the sensitivity and specificity of Helicobacter pylori stool antigen test?

open access: yes, 2003
Background. N-acetyl cystein, a mucolytic agent, might make Helicobacter pylori antigens shed more easily to stool, and might therefore contribute to the diagnostic accuracy of the Helicobacter pylori stool antigen test.
Demirturk, L   +6 more
core   +1 more source

Tofacitinib Regulates β‐Catenin Nuclear Translocation to Inhibit FLS Migration and Alleviate Clinical Symptoms of RA

open access: yesiNew Medicine, EarlyView.
ABSTRACT Objective Tofacitinib is a Janus kinase (JAK) inhibitor approved for the treatment of moderate‐to‐severe rheumatoid arthritis (RA). However, its synovium‐related molecular mechanisms, particularly its regulatory effect on fibroblast‐like synoviocyte (FLS) migration, remain incompletely understood.
Shuqi Fang   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy